Can We use delayed consolidation in chronic lymphocytic leukemia?
The most recently developed initial treatment regimens for chronic lymphocytic leukemia (CLL) are fixed-duration combinations of an inhibitor of Bruton tyrosine kinase (BTKi) and a B-cell lymphoma ...
Authors
- Kerry Anne Rogers (ORCID: https://orcid.org/0000-0001-5748-7874)
- Philip A. Thompson
Institutions
- Peter MacCallum Cancer Centre (AU)
- The Ohio State University (US)
Publication Details
- Journal
- Leukemia & lymphoma/Leukemia and lymphoma
- Published
- 2026-11-14
- DOI
- https://doi.org/10.1080/10428194.2026.2759560
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00